Article Per Year (5 Year)
p-Index From 2021 - 2026
0.23
P-Index
This Author published in this journals
All Journal Indonesian Journal of Obstetrics and Gynecology (Majalah Obstetri dan Ginekologi Indonesia)
Ratnasari Dwi Cahyanti
Faculty of Medicine Universitas Diponegoro Dr. Kariadi General Hospital Semarang
Health Professions Medicine & Pharmacology Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Placenta Accreta Index (PAI) Score Association With Incidence of Placenta Accreta Spectrum, E-Cadherin Expression, Maternal and Neonates Outcome Martina Wibowo; Agoes Oerip Poerwoko; Raden Soerjo Hadijono; Julian Dewantiningrum; Besari Adi Pramono; Ratnasari Dwi Cahyanti; Dik Puspasari; Hermawan Hermawan
Indonesian Journal of Obstetrics and Gynecology Volume 14. No. 2 April 2026
Publisher : Indonesian Socety of Obstetrics and Gynecology

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.32771/inajog.v14i2.2436

Abstract

Objective: To evaluated the Placenta Accreta Index (PAI) score for its association with histopathological diagnosis, E-cadherin expression, and clinical outcomes in Placenta Accreta Spectrum (PAS) disorders.Methods: A retrospective cross-sectional analysis was conducted on 81 patients with PAS at a tertiary referral center. Data on PAI scores, histopathology, and maternal/neonatal outcomes were collected. Statistical analysis compared outcomes between patients with PAI scores ≥4 and <4.Results: A PAI score ≥4 was not significantly associated with the final histopathological diagnosis of PAS (p=1.000). E-cadherin expression was lower in PAS tissue, but not significantly correlated with PAI score. However, a PAI score ≥4 was significantly associated with increased intraoperative blood loss (1275 mL vs. 968 mL, p=0.005) and a higher likelihood of requiring blood transfusion (RR 1.56, 95% CI 1.126–2.150, p=0.007). No significant associations were found between PAI score and adverse neonatal outcomes.Conclusion: The PAI score is a practical tool for predicting surgical morbidity, specifically hemorrhage and transfusion risk, in pregnancies clinically suspected of PAS, supporting its use for preoperative planning in resource-limited settings. Its utility as a primary diagnostic marker for histopathological invasion appears limited in a high-risk referral population.Keywords: E-cadherin, maternal outcome, neonatal outcome, placenta accreta spectrum, PAI Score
Co-Authors Agoes Oerip Poerwoko Besari Adi Pramono Dik Puspasari Hermawan Hermawan Julian Dewantiningrum Martina Wibowo Raden Soerjo Hadijono